Tenax Therapeutics
TENX
16 hedge funds and large institutions have $46.5M invested in Tenax Therapeutics in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.
4,535% more capital invested
Capital invested by funds: $1M → $46.5M (+$45.5M)
220% more funds holding
Funds holding: 5 → 16 (+11)
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
57% more call options, than puts
Call options by funds: $368K | Put options by funds: $234K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$13.1M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12.5M |
| 3 |
HM
HealthCor Management
New York
|
+$9.3M |
| 4 |
BC
Broadfin Capital
New York
|
+$6.14M |
| 5 |
DM
Deerfield Management
New York
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$493K |
| 2 |
Barclays
London,
United Kingdom
|
-$198K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$198K |
| 4 |
EMG
Ellington Management Group
Old Greenwich,
Connecticut
|
-$154K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
27
Barclays
London,
United Kingdom
| $1K | -$198K | -1 | Closed |
|
|
MPWT
28
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $72 | – | – | – |
|
29
BNP Paribas Financial Markets
Paris,
France
| $39 | – | – | – |
|
|
PAG
30
Private Advisor Group
Morristown,
New Jersey
| – | -$493K | -3 | Closed |
|
|
EMG
31
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$154K | -1 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$79K | -1 | Closed |
|
TENX Hedge Fund Activity: Q1 2014 in Review
16 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2014, worth a combined $46.5M — up 4,535% from $1M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TENX positions and 5 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $13.1M. The largest seller was Private Advisor Group, exiting entirely with an estimated $493K sold.
- 16 institutional investors held Tenax Therapeutics (TENX) as of Q1 2014, up from 5 in Q4 2013.
- Funds reported $46.5M of Tenax Therapeutics stock for Q1 2014, up 4,535% quarter-over-quarter.
- 16 funds opened new Tenax Therapeutics positions in Q1 2014 and 5 closed out, a net change of +11 holders.
- The largest Tenax Therapeutics buyer in Q1 2014 was Sabby Management, an estimated $13.1M added.
- The largest Tenax Therapeutics seller in Q1 2014 was Private Advisor Group, an estimated $493K sold.
Based on aggregated 13F filings for Q1 2014.